1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK | BSE: 532296

Glenmark Pharma Live Share Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
In 2 Starfolio Baskets
about

Glenmark Pharmaceuticals Ltd. is a global research-led pharmaceutical company based in India. It maintains a strong commercial presence across more than 80 countries, with significant operations in India, North America, Europe, and emerging markets. ...

Read More
Ask MarketMind AI
2318.40 -1.60 (-0.07%)
29.33% Gain from 52W Low
638.5K
NSE+BSE Volume

NSE 14 Aug, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
Dividend
Glenmark Pharma has an upcoming dividend of ₹2.500 per share due on 31 Aug 2026 See details
Loading... You have run out of DVM views!
Subscribe now to see details
Durability score
High Financial Strength
- / 100
Valuation Score
Mid Valuation
- / 100
Momentum Score
Technically Moderately Bullish
65.2 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM
Analyst Price Target
2,498
1Yr Price target upside is 8%
11 analysts

27

S

4

W

7

O

3

T

SWOT Analysis

Glenmark Pharma Live Price Chart

Switch to TradingView
Switch to

Glenmark Pharma Live Price Chart

Custom


Loading Fundamental data..


Loading data..
Is Glenmark Pharmaceuticals Ltd. worth buying?
581 Votes:
Buy 79.52%
Sell 13.6%
Hold 6.88%
BUY
SELL
HOLD
Ask AI
×